☆ 4.5 Article

Atrial amyloidosis: mechanisms and clinical manifestations

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration

Lena Rivard et al.

Summary: Growing evidence suggests an association between atrial fibrillation (AF) and cognitive impairment and dementia, independent of stroke. The report provides guidance on investigating and managing dementia in AF patients based on the best available evidence. Further research is needed to determine the direct causal effect and explore potential pathophysiological mechanisms.

CIRCULATION (2022)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology

Andrew J. S. Coats et al.

EUROPEAN HEART JOURNAL (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Comparison of left atrial strain by feature-tracking cardiac magnetic resonance with speckle-tracking transthoracic echocardiography

Mina M. Benjamin et al.

Summary: The study compared LA strain measurements using TTE and CMR, finding systematic bias and proportional bias in measurements. There were modest differences in intraobserver reproducibility between the two modalities.

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2022)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Longitudinal strain in the management of cardiac AL amyloidosis: do we need it?

Claudio Rapezzi et al.

EUROPEAN HEART JOURNAL (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Natriuretic Peptide Oligomers Cause Proarrhythmic Metabolic and Electrophysiological Effects in Atrial Myocytes

Zhenjiang Yang et al.

Summary: Natriuretic peptide oligomers increase susceptibility to atrial arrhythmia, and the accelerated formation of oligomers by mutANP is associated with familial atrial fibrillation mutations. Oligomers inhibit mitochondrial function and regulate ion currents in atrial cells.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis JACC State-of-the-Art Review

Claudio Rapezzi et al.

Summary: In the past year, 5 scientific societies have issued documents on cardiac amyloidosis (CA), providing guidance for clinicians managing patients and highlighting areas for further investigation. The documents share similarities regarding diagnosis and treatment, but diverge on specific details, indicating knowledge gaps and unmet needs in CA management.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis

Francesco Bandera et al.

Summary: This study characterized left atrial pathology in explanted hearts with transthyretin amyloid cardiomyopathy (ATTR-CM); assessed left atrial mechanics using echocardiographic speckle tracking in a large cohort of ATTR-CM patients; and studied the association with mortality. The findings revealed extensive atrial infiltration of ATTR amyloid, loss of atrial function, and increased stiffness, which were strong independent predictors of mortality. A distinctive phenotype named atrial electromechanical dissociation (AEMD) was identified in patients in sinus rhythm with poor prognosis.

JACC-CARDIOVASCULAR IMAGING (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis

Alberto Aimo et al.

Summary: Cardiac amyloidosis (CA) affects all four heart chambers, and strain parameters of all chambers are altered in CA patients, particularly those with amyloid transthyretin (ATTR; n = 144, 34%) or amyloid light-chain (AL; n = 117, 28%) CA. Peak left atrial longitudinal strain (LA-PALS) is independently associated with the diagnosis of CA or ATTR-CA beyond standard echocardiographic variables and cardiac biomarkers. Patients with the most severe impairment of LA strain are most likely to have CA or ATTR-CA.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation

Francesco Cappelli et al.

Summary: In a large multicentric cohort of CA patients, the prevalence and incidence rate of AEs was high, with a significant proportion of events occurring despite anticoagulation therapy or in patients in sinus rhythm. A higher CHA2DS2-VASc score may identify patients at risk of AEs, even among those in sinus rhythm.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2021)

Add to Collection

Article Multidisciplinary Sciences

Morpho-functional changes of cardiac telocytes in isolated atrial amyloidosis in patients with atrial fibrillation

Tatyana V. Sukhacheva et al.

Summary: Telocytes in patients with atrial fibrillation and atrial fibrillation with isolated atrial amyloidosis exhibit ultrastructural signs of synthetic, proliferative, and phagocytic activity, and show various immunophenotypes. Despite no significant differences in morphology and immunophenotype of telocytes among patients with different forms of atrial fibrillation, CD68-positive cells are more commonly detected in patients with atrial fibrillation and isolated atrial amyloidosis. In aged patients with atrial fibrillation and isolated atrial amyloidosis, remodeling of atrial myocardium may lead to the transformation of telocytes into transitional forms with characteristics of fibroblast-, histiocyte-, and endotheliocyte-like cells.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis

Jan M. Griffin et al.

Summary: Cardiac amyloidosis, once considered a rare disease, is now increasingly recognized due to aging population and noninvasive diagnostic methods. Better understanding of the pathogenesis of cardiac amyloidosis has led to the development of multiple effective therapies.

CIRCULATION RESEARCH (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia et al.

Summary: Cardiac amyloidosis is a serious infiltrative disease caused by the deposition of amyloid fibrils in the heart, which can be due to genetic variants or acquired conditions. With advances in imaging techniques, non-invasive diagnosis is now possible, showing that cardiac amyloidosis is more common than previously thought. The Working Group on Myocardial and Pericardial Disease has proposed definitions and diagnostic algorithms for cardiac amyloidosis.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans

Masatoshi Minamisawa et al.

Summary: This study showed that carriers of the V122I TTR variant in African-Americans have significant left atrial enlargement and dysfunction compared to non-carriers, suggesting that abnormalities in left atrial function may be early markers of subclinical disease in this population.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black Americans

Senthil Selvaraj et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients With Cardiac Amyloidosis

Peter R. Huntjens et al.

Summary: In patients with cardiac amyloidosis, echocardiographic strain imaging of all four cardiac chambers was found to be significantly associated with survival. Among the strain values, peak longitudinal LA strain showed the strongest association with prognosis. Atrial and ventricular strain have potential clinical utility in predicting outcomes in these patients.

JACC-CARDIOVASCULAR IMAGING (2021)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

The left atrium in cardiac amyloidosis: a valuable but still underused observation window on the overall disease process

Claudio Rapezzi et al.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia et al.

Summary: Cardiac amyloidosis is a serious and progressive infiltrative disease caused by amyloid fibril deposition in the heart. Advances in imaging techniques and diagnostic algorithms have made it possible to diagnose the condition non-invasively. Monitoring and treating cardiac amyloidosis are important in bridging the gap between research advances and clinical practice.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis

Eoin Donnellan et al.

EUROPACE (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings

Giuseppe Vergaro et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis

Nowell M. Fine et al.

CANADIAN JOURNAL OF CARDIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association

Michelle M. Kittleson et al.

CIRCULATION (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Isolated atrial amyloidosis suspected by electrophysiological voltage mapping and diagnosed by 99mTc-DPD scintigraphy

Schoeppenthau Doreen et al.

ESC HEART FAILURE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates

Giovanni Donato Aquaro et al.

IJC HEART & VASCULATURE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation in Transthyretin Cardiac Amyloidosis Predictors, Prevalence, and Efficacy of Rhythm Control Strategies

Eoin Donnellan et al.

JACC-CLINICAL ELECTROPHYSIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis

Edward A. El-Am et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Treatment of cardiac transthyretin amyloidosis: an update

Michele Emdin et al.

EUROPEAN HEART JOURNAL (2019)

Add to Collection

Letter Cardiac & Cardiovascular Systems

High Prevalence of Intracardiac Thrombi in Cardiac Amyloidosis

Ana Martinez-Naharro et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality

Kevin Sanchis et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Transthyretin Amyloid Cardiomyopathy JACC State-of-the-Art Review

Frederick L. Ruberg et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Atrial Fibrillation in the Elderly: The Role of Sub-Clinical Isolated Cardiac Amyloidosis

Darshan Krishnappa et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

Eli Muchtar et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study

Tadafumi Sugimoto et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Therapies for cardiac light chain amyloidosis: An update

Alberto Aimo et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience

Yuliya Y. Mints et al.

ESC HEART FAILURE (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy

Chirag R. Barbhaiya et al.

HEART RHYTHM (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis

Nicholas Y. Tan et al.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

AL (Light-Chain) Cardiac Amyloidosis A Review of Diagnosis and Therapy

Rodney H. Falk et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cumulative Burden of Myocardial Dysfunction in Cardiac Amyloidosis Assessed Using Four-Chamber Cardiac Strain

Yuichiro Kado et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Sherif F. Nagueh et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study

Dania Mohty et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role

Simone Longhi et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Echocardiography in cardiac amyloidosis

Rodney H. Falk et al.

HEART FAILURE REVIEWS (2015)

Add to Collection

Article Cell Biology

Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture

L. A. Sikkink et al.

CELL DEATH & DISEASE (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Intracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis

DaLi Feng et al.

CIRCULATION (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Intracardiac thrombosis and embolism in patients with cardiac amyloidosis

DaLi Feng et al.

CIRCULATION (2007)

Add to Collection

Review Cardiac & Cardiovascular Systems

Depletion of atrial natriuretic peptide during longstanding atrial fibrillation

MP van den Berg et al.

EUROPACE (2004)

Add to Collection

Article Cardiac & Cardiovascular Systems

Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation

O Leone et al.

EUROPEAN HEART JOURNAL (2004)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial amyloidosis -: An arrhythmogenic substrate for persistent atrial fibrillation

C Röcken et al.

CIRCULATION (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.